板塊異動 | CRO行情輪動!泰格醫藥升超4%、康龍化成市中創新高、藥明生物升超5%
uSMART友信智投8月26日消息,週三港股,CRO板塊強勢,截至11:19分,次新股泰格醫藥一度升超4%,市中最高觸及118.6港元,距離上市巔峰的119港元,僅一步之遙!康龍化成一度升超5%,市中最高觸及93.2港元,股價刷新歷史高位!藥明生物一度升超6%,最高觸及189港元,逼近歷史高位。
康龍化成將於8月26日(星期三)發佈截至2020年6月30日止六個月業績。
泰格醫藥將於8月28日(星期五)發佈2020年6月30日止六個月的未經審計中期業績。
藥明生物則已於8月17日晚間公佈2020年上半年業績,營業收入同比增長21.0%至約19.4億元人民幣,經調整淨利潤則同比增長40.7%至約7.3億人民幣,均大幅超越市場預期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.